Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling

NCT00438776 is registered in ClinicalTrials.gov with Lindner Center of HOPE as lead sponsor.

NCT NCT00438776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00438776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling
Lead sponsor
Lindner Center of HOPE
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2007
Completion date
March 31, 2009
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pathological gambling